Overview

  • Product nameDoxazosin mesylate
  • Description
    Selective α1 adrenoceptor antagonist
  • Biological descriptionSelective α1 adrenoceptor antagonist (pKi values are 9.0, 8.5 and 8.4 at α1B, α1A and α1D receptors, respectively). Shows antihypertensive activity and induces apoptosis.
  • Purity> 99%

Properties

    References for Doxazosin mesylate (ab120754)

    This product has been referenced in:
    • Garrison JB & Kyprianou N Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway. Cancer Res 66:464-72 (2006). Read more (PubMed: 16397262) »
    • González-Juanatey JR  et al. Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alpha1-adrenergic blockade. Circulation 107:127-31 (2003). Read more (PubMed: 12515754) »
    • Kenny BA  et al. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies. Br J Pharmacol 118:871-8 (1996). Read more (PubMed: 8799556) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120754.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"